MCA-3D Cells

The MCA-3D cell line is derived from primary mouse epidermal cultures that exhibit resistance to calcium-induced terminal differentiation. These cells were initially treated with the carcinogens N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) or 7,12-dimethylbenz[a]anthracene (DMBA), and subsequently exposed to 12-O-tetradecanoylphorbol-13-acetate (TPA). The resistance to terminal differentiation was assessed by elevating calcium levels in the culture medium to 1.2 mM, which selectively allows for the growth of transformed cells while normal cells typically undergo terminal differentiation and death. The MCA-3D cell line displays an epithelial morphology and forms well-defined colonies in culture. Ultrastructural analysis reveals that MCA-3D cells contain keratin filaments and desmosomes, which are indicative of their epithelial origin and suggest maintenance of some degree of normal keratinocyte differentiation. However, the exact abundance of these structures can vary among subpopulations within the line. MCA-3D cells have been tested for tumorigenicity by subcutaneous injection into syngeneic Balb/c neonates, with results indicating that this line is non-tumorigenic, even after prolonged culture in high calcium conditions. Additionally, the MCA-3D cells do not grow in soft agar, further supporting their non-malignant phenotype. Biochemical assays for gamma glutamyl transpeptidase (GGT) activity and transglutaminase activity have shown that MCA-3D cells are negative for GGT, and their transglutaminase activity does not correlate with tumorigenic potential, aligning with their non-tumorigenic classification. Overall, the MCA-3D cell line serves as a model for studying the early stages of carcinogenesis and the factors that influence the progression from preneoplastic lesions to fully malignant tumors.